Hi Supertramp,
Your score of cce as 1 out of 8 on the biotech checklist. Let's keep it in context.
1. Successful products on the market - no. Not commercially successful & possibly not successful as a treatment, judging by sales. [They are proven products - no sales do not mean not successful. They have sales previously for the three products. We have no knowledge as to why the uptake of CCE's products has been slowed - Previously CEO,Troels, mentioned the surgeons were slowed at using the products. I think the products are expensive and also the procedures of efficacy may not be undertaken properly - they had this problem in Japan earlier. There are a whole range of issues but somehow there is no explanation being given by CCE the reason why uptake has been slowed]
2. A deep product pipeline with late-stage candidates - no. Three branded products, but all the same really (only ReCell available now). [Although the two, apart from ReCell, are the same There are still three products. They have to put aside ulcer because of cash burn]
3. Drugs and candidates that target large or underserved markets - yes, I guess
4. Partnerships and marketing agreements with blue-chip drug manufacturers - no [ They don't have it currently as they thought they could go it alone but realise that they need to tap into blue-chip partners/alliances to sell their products - at least they are looking at it now]
5. Research & development spending - no [No longer given that CCE is trying to conserve cash resources. It is a question about optimising resource allocation given that capital raising may not be forthcoming and that sale revenues may be slow. So, you would spend on areas that give you a better return than to burn cash and having no investment returns.]
6. Enough cash to fund operations for two years - no [unless they manage to pull in sale revenues at later stage. ]
7. Experienced management - no (the old management has proved to be very poor so far) - [They should have kept Troels]
8. Favorable financial analysis - no
- Forums
- ASX - By Stock
- CCE
- where do we go from now
CCE
carnegie clean energy limited
Add to My Watchlist
5.56%
!
5.1¢

where do we go from now, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
5.1¢ |
Change
-0.003(5.56%) |
Mkt cap ! $18.67M |
Open | High | Low | Value | Volume |
5.5¢ | 5.5¢ | 5.1¢ | $12.04K | 226.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 87976 | 5.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.2¢ | 21400 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 87976 | 0.051 |
5 | 171100 | 0.050 |
2 | 117101 | 0.049 |
2 | 182000 | 0.048 |
1 | 20000 | 0.045 |
Price($) | Vol. | No. |
---|---|---|
0.052 | 21400 | 1 |
0.055 | 517789 | 2 |
0.056 | 90752 | 2 |
0.057 | 19732 | 1 |
0.058 | 75969 | 2 |
Last trade - 15.01pm 23/07/2025 (20 minute delay) ? |
Featured News
CCE (ASX) Chart |